Breaking news & key AI updates in healthcare, medicine & pharma/biotech
Large multimodal models jump from roughly 60% to 80% accuracy on neuroradiology cases when answer choices are provided.
HHS commits NIH resources to Trump's $5B Genesis Mission, targeting chronic disease, pediatric cancer, and…
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug…
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
MD Anderson researchers develop AI-guided technique to map brain tumor blood supply, enabling more precise…
Belgian AI drug discovery startup Sightera Biosciences raises $3.2M to advance molecular glue therapies for…